Literature DB >> 10423513

[Analysis of the cases in which Schizophyllum commune was isolated].

K Kamei1, H Unno, J Ito, K Nishimura, M Miyaji.   

Abstract

Infections caused by Schizophyllum commune have recently been on the increase. We analyzed cases in which this fungus was isolated from clinical samples from 1991 to 1995. Regular morphological methods were first employed in the identification of S. commune, and when necessary, mating was made with a known S. commune isolate. IgG antibodies against S. commune in the patients' serum were determined by the ELISA method. Profiles of the cases were analyzed and the English-language medical literature was reviewed. S. commune was isolated from 12 patients. Eighty three percent of the patients were female, most of which presented with allergy-related pulmonary diseases, i. e. allergic bronchopulmonary mycosis or mucoid impaction of bronchi. IgG antibodies were detectable in nine of eleven patients examined (82%). Fifty eight percent of the isolates were monokaryotic, and therefore, unidentifiable by regular morphological methods. In contrast, analysis of the English literature disclosed that sinusitis is the most common form of infection, and that hyphal invasion into the tissue was seen in 50% of reported cases. Our study shows that S. commune should be regarded as a pathogenic fungus, and is infecting humans much more frequently than previously assumed. Further investigation is warranted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423513     DOI: 10.3314/jjmm.40.175

Source DB:  PubMed          Journal:  Nihon Ishinkin Gakkai Zasshi        ISSN: 0916-4804


  8 in total

1.  Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.

Authors:  Anuradha Chowdhary; Shallu Kathuria; Pradeep Kumar Singh; Kshitij Agarwal; Shailendra N Gaur; Pradip Roy; Harbans S Randhawa; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

2.  Development of molecular methods for identification of Schizophyllum commune from clinical samples.

Authors:  W Buzina; D Lang-Loidolt; H Braun; K Freudenschuss; H Stammberger
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  A case of Schizophyllum commune sinusitis following unrelated cord blood transplantation for acute lymphoblastic leukemia.

Authors:  Takashi Toya; Akihito Shinohara; Keita Tatsuno; Sachiko Seo; Yasuhito Nannya; Motoshi Ichikawa; Koichi Makimura; Kyoji Moriya; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-05-18       Impact factor: 2.490

4.  Allergic fungal sinusitis associated with Trichoderma longibrachiatum.

Authors:  Patrick Tang; Subhash Mohan; Lynne Sigler; Ian Witterick; Richard Summerbell; Iivi Campbell; Tony Mazzulli
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

5.  A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune.

Authors:  Haruki Kobayashi; Tetsuhiko Taira; Kazushige Wakuda; Toshiaki Takahashi; Masahiro Endo
Journal:  Respir Med Case Rep       Date:  2016-07-17

6.  Allergic fungal sinusitis caused by Schizophyllum commune.

Authors:  Xiang Liu; Hua Zou; Qiu-Jian Chen; Chang-Ming Lu
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2017-03-27

7.  First report on cutaneous infectious granuloma caused by Schizophyllum commune.

Authors:  Lidi Tian; Yunzhu Mu; Hao Zhang; Xiaocui Su; Chuan Yang; Xianzhu Shu; Defu Qing
Journal:  BMC Infect Dis       Date:  2018-06-26       Impact factor: 3.090

8.  Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi.

Authors:  Takashi Ishiguro; Noboru Takayanagi; Daidou Tokunaga; Kazuyoshi Kurashima; Aya Matsushita; Keiji Harasawa; Koichiro Yoneda; Noriko Tsuchiya; Shozaburo Yamaguchi; Yousuke Miyahara; Ryozo Yano; Hiroo Saito; Mikio Ubukata; Tsutomu Yanagisawa; Yutaka Sugita; Yoshinori Kawabata
Journal:  Yale J Biol Med       Date:  2007-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.